Literature DB >> 12081007

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

Jonathan E Kaplan1, Henry Masur, King K Holmes.   

Abstract

In 1995, the U.S. Public Health Service (USPHS) and the Infectious Diseases Society of America (IDSA) developed guidelines for preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV); these guidelines were updated in 1997 and 1999. This fourth edition of the guidelines, made available on the Internet in 2001, is intended for clinicians and other health-care providers who care for HIV-infected persons. The goal of these guidelines is to provide evidence-based guidelines for preventing OIs among HIV-infected adults and adolescents, including pregnant women, and HIV-exposed or infected children. Nineteen OIs, or groups of OIs, are addressed, and recommendations are included for preventing exposure to opportunistic pathogens, preventing first episodes of disease by chemoprophylaxis or vaccination (primary prophylaxis), and preventing disease recurrence (secondary prophylaxis). Major changes since the last edition of the guidelines include 1) updated recommendations for discontinuing primary and secondary OI prophylaxis among persons whose CD4+ T lymphocyte counts have increased in response to antiretroviral therapy; 2) emphasis on screening all HIV-infected persons for infection with hepatitis C virus; 3) new information regarding transmission of human herpesvirus 8 infection; 4) new information regarding drug interactions, chiefly related to rifamycins and antiretroviral drugs; and 5) revised recommendations for immunizing HIV-infected adults and adolescents and HIV-exposed or infected children.

Entities:  

Mesh:

Year:  2002        PMID: 12081007

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  82 in total

1.  Antibiotics for Travelers: What's Good and What's Not.

Authors:  Kathryn N. Suh; Jay S. Keystone
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

Review 2.  Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors:  Eva M Carmona; Andrew H Limper
Journal:  Ther Adv Respir Dis       Date:  2010-08-24       Impact factor: 4.031

Review 3.  [The radiology of opportunistic pneumonias. I: Epidemiological, laboratory and clinical background].

Authors:  S Tuengerthal
Journal:  Radiologe       Date:  2005-04       Impact factor: 0.635

4.  Comparison of Microcapillary Cytometry Technology and Flow Cytometry for CD4+ and CD8+ T-Cell Estimation.

Authors:  A J Kandathil; R Kannangai; S David; G Nithyanandam; S Solomon; P Balakrishnan; O C Abraham; S Subramanian; P Rupali; V P Verghese; S Pulimood; G Sridharan
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

Review 5.  Human papillomavirus infections in primary care.

Authors:  Folashade Ogunmodede; Steven H Yale; Bruce Krawisz; Gregory C Tyler; Anthony C Evans
Journal:  Clin Med Res       Date:  2007-12-17

6.  Foodborne infections.

Authors: 
Journal:  Paediatr Child Health       Date:  2008-11       Impact factor: 2.253

7.  Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Henry Masur; John T Brooks; Constance A Benson; King K Holmes; Alice K Pau; Jonathan E Kaplan
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

8.  Hepatitis C virus testing perspectives among primary care physicians in four large primary care settings.

Authors:  Amy Jewett; Arika Garg; Katherine Meyer; Laura Danielle Wagner; Katherine Krauskopf; Kimberly A Brown; Jen-Jung Pan; Omar Massoud; Bryce D Smith; David B Rein
Journal:  Health Promot Pract       Date:  2014-04-28

Review 9.  Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.

Authors:  Kuan-Yeh Lee; Mao-Song Tsai; Kuang-Che Kuo; Jen-Chih Tsai; Hsin-Yun Sun; Aristine C Cheng; Sui-Yuan Chang; Chen-Hsiang Lee; Chien-Ching Hung
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

10.  Successful completion of pregnancy in a woman with chronic granulomatous disease.

Authors:  Michi Hisano; Shinichi Kobayashi; Naoko Arata; Atsuko Murashima; Koushi Yamaguchi
Journal:  Obstet Med       Date:  2011-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.